Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. - Wikidata - awgldk - TriplyDB

Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.

Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.

http://www.wikidata.org/entity/Q35853576

about

Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer Methylseleninic acid sensitizes Notch3-activated OVCA429 ovarian cancer cells to carboplatin Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes.Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL rats 1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and Apoptosis.Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compounds.The selenium metabolite methylselenol regulates the expression of ligands that trigger immune activation through the lymphocyte receptor NKG2D Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.Enhanced apoptotic effects by the combination of curcumin and methylseleninic acid: potential role of Mcl-1 and FAK.Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancer Methylselenocysteine: a promising antiangiogenic agent for overcoming drug delivery barriers in solid malignancies for therapeutic synergy with anticancer drugs The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study.Soy content of basal diets determines the effects of supplemental selenium in male mice Methylselenocysteine preventing castration-resistant progression of prostate cancer Biomarkers of selenium status Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells.Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes.Effects of Selenium Yeast on Oxidative Stress, Growth Inhibition, and Apoptosis in Human Breast Cancer Cells.Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.Induction of lung glutathione and glutamylcysteine ligase by 1,4-phenylenebis(methylene)selenocyanate and its glutathione conjugate: role of nuclear factor-erythroid 2-related factor 2.Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells.Melanoma prevention using topical PBISe Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges.Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition.The selenium analog of the chemopreventive compound S,S'-(1,4-phenylenebis[1,2-ethanediyl])bisisothiourea is a remarkable inducer of apoptosis and inhibitor of cell growth in human non-small cell lung cancer Selenium for the prevention of cutaneous melanoma.Selenium supranutrition: are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistance?Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia.Is selenium a potential treatment for cancer metastasis?Methaneseleninic acid and γ-Tocopherol combination inhibits prostate tumor growth in Vivo in a xenograft mouse model Upregulation of KLF4 by methylseleninic acid in human esophageal squamous cell carcinoma cells: Modification of histone H3 acetylation through HAT/HDAC interplay.

P2860

Q21134780-13A72F6B-AB0A-4F52-B70F-BFEC9FEEC2D7 Q28540634-7BB0908F-643A-4FD5-8FEE-40C1F5BA19C0 Q30986928-349A2526-33A8-4DD3-9AFC-0752032ADE20 Q33573583-DA36FDF2-9B63-4FAE-9C36-5359C68F363E Q33657004-80314151-A226-4252-9DF7-60AB0CE9ED78 Q33657012-11130197-6CEC-4C14-9ADD-A557B8031BB2 Q33708061-B0176436-C8D8-4670-B867-A6A47D962091 Q33981807-53B4095F-E658-4177-AF4A-724E6B3731E2 Q34025688-615A8A0F-58F7-479E-BDA8-99020DA880D9 Q34074062-8D7F0672-180C-4D5B-B5CE-4AA1A3EF74D3 Q34128573-5A63DED3-21B2-47F6-ADEF-A0065B8CDAEE Q34249695-1C57324A-CD68-4892-8119-C18CC8A4E248 Q34467682-0498658C-5E8E-4C65-ABC7-18F7A42F3D3F Q34500651-85EDEDA5-3B4E-4D7D-BD2A-38DDA0CB9CAA Q34639407-091B0B28-142D-4371-B2C3-FC4DB41543E2 Q34663140-00BA9202-D5BB-44B5-BD8D-AE502D046A3F Q35034404-BAA98428-4DB0-48DA-8E9F-77CF19EB8EC8 Q35154355-68985F8F-B8AF-45E7-BB95-B900EA6D670F Q35572551-257A15EB-F00A-4DBE-A611-56DCF3A9BE02 Q35582612-8B04CC07-D8A3-4EFB-B906-B137EBAFEEF2 Q35585857-73F6A41E-5F7C-4873-9178-C1617E3DEADD Q35903767-1BBCA535-E84D-49EA-A4FB-69463735E52D Q36001073-322C17D1-45E1-4DA9-912F-5DDC64B03C3C Q36064295-8730FA05-256E-41FF-9C8E-9709ED3CF9F7 Q36185212-A5618942-EFD4-42F2-BB62-A2DC053B8F74 Q36330004-867A47BD-23C1-4EAC-A730-712FA860065A Q36336545-57985927-57C4-4015-860B-8FAB1D696C19 Q36384802-F3F8F586-5404-4068-B229-F8EF76EE6AB3 Q36429602-C546CCF5-9B78-4EAC-93F2-2CA0C405A7FA Q36446645-33A3161D-09DF-436E-8FC7-B00BB131F813 Q36769227-ACA56FA7-F238-4909-A86D-A958D6DAFD75 Q36849537-9CD7E9A7-2FAC-46BD-AF9E-59B265BD6321 Q36950580-3F8F10C1-9C57-4BA0-B995-A06B77F3A805 Q36993984-C18D42B8-1665-43FF-AEB4-2DB64B45FF49 Q36994096-5F8E8B73-7061-4EA1-BA9B-C20B49419919 Q37468577-DA9B628D-D896-49C6-982A-7D31EF408A46 Q37703369-F87E4F12-933F-4626-99AC-8F365F78C879 Q38097279-5C2DFB68-F2EE-45C3-9626-D0E266EFAD2A Q38977087-CD038AE7-68CE-4A5C-A564-FBA430D2D951 Q38999422-21EC233F-2362-4F9E-ABEC-CBAB0CED45C8

P2860

Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.

http://www.wikidata.org/entity/Q35853576

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Superior in vivo inhibitory ef ...... selenomethionine or selenite.

@ast

Superior in vivo inhibitory ef ...... selenomethionine or selenite.

@en

type

label

Superior in vivo inhibitory ef ...... selenomethionine or selenite.

@ast

Superior in vivo inhibitory ef ...... selenomethionine or selenite.

@en

prefLabel

Superior in vivo inhibitory ef ...... selenomethionine or selenite.

@ast

Superior in vivo inhibitory ef ...... selenomethionine or selenite.

@en

P1433

Q35853576-4E073CAE-0041-4F89-8A52-C2B0479B2E73

P1476

Q35853576-003CD1B1-564F-47AD-BEEC-3B0877777FB6

P2093

Q35853576-0F879471-6F6E-4536-9AFC-7641C8579948

Q35853576-19698C10-F18E-4303-945D-75FC8842971D

Q35853576-3F0A1E3A-0465-4ED6-A087-BAFC64964F59

Q35853576-913FEADF-9DFE-42E2-9B17-98FAC2E9FC19

Q35853576-D00B57D9-1B43-4AE3-8432-85735A3F720D

Q35853576-DDB035CF-F7ED-4C71-BB85-EE8CD3A91E5D

Q35853576-F12E29CC-BF35-4C88-A356-E7480D0B1EDA

P2860

Q35853576-00F0E8B6-32CE-47E4-B1A0-DBDEC27C66E4

Q35853576-05690C0D-EECD-4E9D-812C-35393FDC0F1B

Q35853576-0E73176A-90AE-43BC-B6F9-20DB37E2F19D

Q35853576-10E50307-12F3-41B3-BF67-05AAD9E84422

Q35853576-194728B3-219F-46DC-A150-E39CD9A68CE1

Q35853576-3ECDBCD5-F4DD-427F-8C4F-1744BA1C0B02

Q35853576-49F977CF-538C-4C5C-9D3B-38D98A602EBD

Q35853576-4DFB744F-A81C-4011-8C9F-6664CEA2E5A7

Q35853576-7EEC9E35-288C-4D03-904F-E03B29AE57FF

Q35853576-8A3E676A-B39D-459C-B794-AA897B8ADA1E

P304

Q35853576-2AFEB910-7420-4993-81F9-B86156E0F72F

P31

Q35853576-CEBA2305-7055-4992-A24E-72D97944ABDF

P356

Q35853576-00B9D1CB-AD10-4AD9-8827-69355249D5BE

P407

Q35853576-CF61219E-DF78-42E5-B1CB-B58D91268C9C

P433

Q35853576-7A108888-1AE1-4AB2-B7CC-B4B687D0E818

P478

Q35853576-3E7EAD28-8F39-43FE-BEFB-51E709FA5F61

P50

Q35853576-CE6137BF-3C6B-475D-ABDE-B334AFBF269E

P577

Q35853576-CCDBB9A0-C0C8-4189-8DCB-603EEA330D70

P5875

Q35853576-A4A3CB8E-7127-48EF-BEF8-B5D1CA29E0DA

P698

Q35853576-8D475AC3-92E7-493E-B4E6-CFE285702893

P932

Q35853576-9800A729-0F3E-45E5-A153-EF516B80BD28

P356

P1433

P1476

Superior in vivo inhibitory ef ...... r selenomethionine or selenite

@en

P2093

Gerald F Combs

http://www.w3.org/2001/XMLSchema#string

Guang-xun Li

http://www.w3.org/2001/XMLSchema#string

Hongbo Hu

http://www.w3.org/2001/XMLSchema#string

Hyo-Jeong Lee

http://www.w3.org/2001/XMLSchema#string

Jennifer C Watts

http://www.w3.org/2001/XMLSchema#string

Joshua D Liao

http://www.w3.org/2001/XMLSchema#string

Zhe Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue selenium levels in selenium-supplemented rats and their relevance in mammary cancer protection

Cancer statistics, 2006

In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention.

Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells.

Lessons from basic research in selenium and cancer prevention.

The current role of chemotherapy in metastatic hormone-refractory prostate cancer.

Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.

Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).

Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts.

Inorganic selenium retards progression of experimental hormone refractory prostate cancer.

P304

1005-1012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGN007

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5542485

http://www.w3.org/2001/XMLSchema#string

P698

18310093

http://www.w3.org/2001/XMLSchema#string

P932

3312608

http://www.w3.org/2001/XMLSchema#string